Serum thymidine kinase 1 levels predict prostate cancer-specific survival

Teemu J. Murtola, Paavo Raittinen, Teuvo Tammela

Research output: Contribution to journal › Meeting Abstract › Scientific › peer-review

Original language	English
Number of pages	2
Journal	Cancer Research
Volume	80
Issue number	16
DOIs	https://doi.org/10.1158/1538-7445.AM2020-LB-149
Publication status	Published - Aug 2020
MoE publication type	Not Eligible
Event	Annual Meeting of the American Association for Cancer Research - Virtual, Online Duration: 22 Jun 2020 → 24 Jun 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{323bec5d71604f0c98e2e307aad2f8b4,

title = "Serum thymidine kinase 1 levels predict prostate cancer-specific survival",

author = "Murtola, {Teemu J.} and Paavo Raittinen and Teuvo Tammela",

year = "2020",

month = aug,

doi = "10.1158/1538-7445.AM2020-LB-149",

language = "English",

volume = "80",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research",

number = "16",

note = "Annual Meeting of the American Association for Cancer Research, AACR ; Conference date: 22-06-2020 Through 24-06-2020",

}

TY - JOUR

T1 - Serum thymidine kinase 1 levels predict prostate cancer-specific survival

AU - Murtola, Teemu J.

AU - Raittinen, Paavo

AU - Tammela, Teuvo

PY - 2020/8

Y1 - 2020/8

U2 - 10.1158/1538-7445.AM2020-LB-149

DO - 10.1158/1538-7445.AM2020-LB-149

M3 - Meeting Abstract

SN - 0008-5472

VL - 80

JO - Cancer Research

JF - Cancer Research

IS - 16

T2 - Annual Meeting of the American Association for Cancer Research

Y2 - 22 June 2020 through 24 June 2020

ER -